Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery

Atherosclerosis

Volumn 137, Issue 1, 1998, Pages 175-186

  Linden T ^a   Taddei Peters, W ^c   Wilhelmsen, L ^b   Herlitz, J ^a   Karlsson, T ^b   Ullstrom C ^a   Wiklund, O ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Inst of Heart and Lung Dis G   (Sweden)

^c Perimmune Inc   (United States)

Author keywords

ApoAI; ApoB; Coronary angiography; Coronary artery disease; Isoforms of apo(a); Lipoprotein(a); Prognosis; Serum lipids

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN A; TRIACYLGLYCEROL;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; FEMALE; FOLLOW UP; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; APOLIPOPROTEINS A; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPIDS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; TIME FACTORS;

EID: 0032478154     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00247-5     Document Type: Article

References (57)

1. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H Lipoprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. Br Med J. 301:1990;1248-1251.
2. Hearn JA, DeMaio AJ, Roubin GS, Hammarström M, Sgoudas D Predictive value of lipoprotein(a) and other serum lipoproteins in the angiographic diagnosis of coronary artery disease. Am J Cardiol. 66:1990;1176-1180.
3. Sigurdsson G, Baldursdottir A, Sigvaidason H, Agnarsson U, Thorgeirsson G, Sigfusson N Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. Am J Cardiol. 69:1992;1251-1254.
4. Wald NJ, Law M, Watt HC, Wu T, Bailey A, Johnson AM, Craig WY, Ledue TB, Haddow JE Apolipoproteins and ischaemic heart disease: implications for screening. Lancet. 343:1994;75-79.
5. Schaefer E, Lamon-Fava S, Jenner J, McNamara J, Ordovase J, Davis CE, Abolafia JM, Lippel K, Levy RI Lipoprotein(a) levels and risk of coronary heart disease in men: The Lipid Research Clinics Coronary Primary Prevention Trial. J Am Med Assoc. 271:1994;999-1003.
6. Bostum AG, Gagnon DR, Cupples LA, Wilson PWF, Jenner JL, Ordovas JM, Schaefer E A prospective investigation of elevated lipoprotein(a) detected by electrophoresis and cardiovascular disease in women. Circulation. 90:1994;1688-1695.
7. Cremer P, Nagel D, Labrot B, Mann H, Muche R, Elster H, Seidel D Lipoprotein(a) as a predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest. 24:1994;444-453.
8. Dahlén GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM Jr. Association of lipoprotein Lp(a), plasma lipids and other lipoproteins with coronary artery disease documented by angiography. Circulation. 74:1986;758-765.
9. Durrington PN, Ishola M, Hunt L, Arrol S, Bhatnagar D Apolipoproteins(a), AI, and B and parental history in men with early onset ischaemic heart disease. Lancet. 1:1988;1070-1073.
10. Sandkamp M, Funke H, Schulte H, Kohler E, Assman G Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin Chem. 36:1990;20-23.
11. Budde T, Fechtrup C, Bösenberg E, Vielhauer C, Enbergs A, Schulte H, Assmann G, Breithardt G Plasma Lp(a)levels correlate with number, severity and length-extension in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis. Arterioscler Thromb. 14:1994;1730-1736.
12. Genest J Jr., McNamara JR, Ordovas JM, Jenner JL, Silberman SR, Andersson KM, Wilson PWF, Salem DN, Schaeffer EJ Lipoprotein cholesterol, apolipoprotein AI and B and lipoprotein(a) abnormalities in men with premature coronary artery disease. J Am Coll Cardiol. 19:1992;792-802.
13. Rhoads GG, Dahlén GH, Berg K, Morton NE, Dannenberg AL Lp(a) lipoprotein as a risk factor for myocardial infarction. J Am Med Assoc. 256:1986;2540-2544.
14. Hoefler G, Harnoncourt F, Paschke E, Mirtl W, Pfeiffer KH, Kostner GM Lipoprotein Lp(a). A risk factor for myocardial infarction. Arteriosclerosis. 8:1988;398-401.
15. Wiklund O, Angelin B, Olofsson SO, Eriksson M, Fager G, Berglund L, Bondjers G Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia. Lancet. 335:1990;1360-1363.
16. Genest JJ Jr., Jenner JL, McNamara JR, Ordovas JM, Silberman SR, Wilson PWF, Schaefer EJ Prevalence of lipoprotein(a) (Lp(a)) excess in coronary artery disease. Am J Cardiol. 67:1991;1039-1045.
17. Hoff HF, Beck GJ, Skibinski CI, Jürgens G, O'Neil J, Kramer J, Lytle B Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery by-pass surgery in patients. Circulation. 77:1988;1238-1244.
18. Jauhiainen M, Koskinen P, Ehnholm C, Frick MH, Mänttäri M, Manninen V, Huttunen JK Lipoprotein(a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis. 89:1991;59-67.
19. Ridker PM, Hennekens CH, Stampfer MJ A prospective study of lipoprotein(a) and the risk of myocardial infarction. J Am Med Assoc. 270:1993;2195-2199.
20. Marcovina SM, Hobbs HH, Albers JJ Relation between number of apolipoprotein(a) kringle-4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature. Clin Chem. 42:1996;436-439.
21. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C Lp(a) glycoprotein phenotypes: inheritance and relation to Lp(a) lipoprotein concentrations in plasma. J Clin Invest. 80:1987;458-465.
22. Marcovina SM, Albers JJ, Jacobs DR Jr., Perkins LL, Lewis CE, Howard BV, Savage P Lipoprotein(a) concentrations and apoliprotein(a) phenotypes in Caucasian and African Americans. Arterioscler Thromb. 13:1993;1037-1045.
23. Johannsson G, Oscarsson J, Rosén T, Wiklund O, Olsson G, Wilhelmsen L, Bengtsson B-Å Effects of 1 year growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Influence of gender and apo(a) and apoE phenotypes. Arteriol Thromb Vascul Biol. 15:1995;2142-2150.
24. de Bruin TWA, van Barlingen H, van Linde-Sibenius Trip M, van Vuurst de Vries A-R, Akveld MJ, Erkelens DW Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid and hyperthyroid subjects. J Clin Endocrin Metab. 76:1993;121-126.
25. Soma MR, Osnado-Gadda I, Paoletti R, Fumagalli R, Morrisett JD, Meschia M, Crosignani P The lowering of lipoprotein(a) induced by estrogen plus progesterone replacement therapy in postmenopausal women. Arch Intern Med. 153:1993;1462-1468.
26. Wilhemsen L., Johansson S., Rosengren A., Wallin I., Dotevall A., Lapas G. Risk factors for cardiovascular disease the period 1985-1995 in Göteborg, Sweden. The GOT-MONICA Project. J Intern Med. 242:1997;199-211.
27. Lindén T, Bondjers G, Karlsson T, Wiklund O Serum triglycerides and HDL cholesterol-major predictors of long-term survival after coronary surgery. Eur Heart J. 15:1995;747-752.
28. Friedewald WT, Levy RL, Fredrickson DS Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifugation. Clin Chem. 18:1972;499-502.
29. Taddei-Peters WC, Butman BT, Jones GR, Venetta TM, Macomber PF, Ransom JH Quantification of lipoprotein(a) particles containing various apolipoprotein(a) isoforms by a monoclonal anti-apo(a) capture antibody and a polyclonal anti-apolipoprotein B detection antibody sandwich enzyme immunoassay. Clin Chem. 39:1993;1382-1389.
30. Kostner GM. The physiological role of Lp(a). In: Scanu AM, editor. Lipoprotein(a). Orlando: Academic Press, 1990:183-204.
31. Armstrong VW, Cremer P, Eberle E, Manke A, Schulze F, Wieland H, Kreuzer H, Siedel D The association between serum Lp(a) concentration and angiographically assessed coronary atherosclerosis: dependence on serum LDL levels. Atherosclerosis. 62:1986;249-257.
32. Labeur C, De Bacquer D, De Backer G, Vincke J, Muyldermans L, Vandekerckhove Y, Van der Stichele E, Rosseneu M Plasma lipoprotein(a) values and severity of coronary artery disease in a large population of patients undergoing coronary angiography. Clin Chem. 38:1992;2261-2266.
33. Bolibar I, Thompson SG, von Eckardstein A, Sandkamp M, Assman G Dose-response relationships of serum lipid measurements with the extent of coronary stenosis. Arterioscler Thromb. Vasc Biol. 15:1995;1035-1042.
34. Watts GF, ap Gwilym RM, Mazurkiewicz J, Colart J Independent correlationbetween plasma lipoprotein(a) and angiographic coronary artery disease in NIDDM. Diabetes Care. 18:1995;234-236.
35. Wang XL, Tam C, McCredie RM, Wilcken DE Determinants of severity of coronary artery disease in Australian men and women. Circulation. 89:1994;1974-1989.
36. Sunayama S, Daida H, Mokuno H, Miyano H, Yokoi H, Joon Lee Y, Sakurai H, Yamaguchi H Lack of increased coronary atherosclerotic risk due to elevated lipoprotein(a) in women >55 years of age. Circulation. 94:1996;1263-1268.
37. Stiel GM, Reblin T, Buhrlen M., Lattermann A, Nienaber CA Differences in lipoprotein(a) and apolipoprotein(a) levels in men and women with advanced coronary atherosclerosis. Coron Artery Dis. 6:1995;347-350.
38. Kraft HG, Lingenhel A, Köchl S, Hoppichler F, Kronenberg F, Abe A, Mühlberger V, Schönitzer D, Utermann G Apolipoprotein(a) kringle-iv repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vasc Biol. 16:1996;713-719.
39. Parlavecchia M, Pancaldi A, Taramelli R, Valsania, P., Galli L, Pozza G, Chierchia S, Ruotoli G. Evidence that apo(a) phenotype is a risk factor for coronary artery disease in men <55 years of age. Am J Cardiol 1994;74:346-351.
40. Sandholzer C, Saha N, Kark JD, Rees A, Jaross W, Dieplinger H, Hoppichler F, Boerwinkle E, Uterman G Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. Arterioscler Thromb. 12:1992;1214-1226.
41. Kark JD, Sandholzer C, Friedlander Y, Utermann G Plasma Lp(a), apo(a) isoforms and acute myocardial infarction in men and women: a case-control study in the Jerusalem population. Atherosclerosis. 98:1993;139-151.
42. Kraft HG, Lingenhel A, Hoppichler F, Kronenberg F, Abe A, Schonitzer D, Uterman G Apolipoprotein(a) kringle-iv repeat number predicts risk for coronary heart disease. Arterioscler Throm Vasc Biol. 16:1996;713-719.
43. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest. 90:1992;52-60.
44. Sandholzer C, Hallman DM, Saha N, Sigurdsson G, Lackner C, Császár A, Boerwinkle E, Uterman G. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in seven ethnic groups. Hum Genet. 86:1991;607-614.
45. Cosgrove DM, Loop FD, Lytle BW, Gill CC, Golding LAR, Gibson C, Stewart RW, Taylor PC, Goormastic M Predictors of reoperation after myocardial revascularization. J Thorac Cardiovasc Surg. 92:1986;811-821.
46. Fox M, Gruchow H, Barboriak J, Andersson AJ, Hoffmann RG, Flemma RJ, King JF Risk factors among patients undergoing repeat aorto-coronary by-pass procedures. J Thorac Cardiovasc Surg. 93:1986;56-61.
47. Campeau L, Enjalbert M, Lesperence L, Bourassa MG, Kwiterovich P, Wacholder S, Sniderman A The relationship of risk factors to the development of atherosclerosis in saphenous vein by-pass grafts and the progression of disease in the native circulation. New Engl J Med. 311:1984;1329-1332.
48. Laird-Meeter K, Penn OC, Haalebos MM, vanDomburg R, Lubsen J, Bos E, Hugenholtz PG Survival in 1041 patients with consecutive aorto-coronary by-pass operations. Eur Heart J. 5:1984;35-42.
49. Varnauskas E, The European Coronary Surgery Study Group. Twelve year follow-up of survival in the randomized European Coronary Surgery Study. New Engl J Med 1988;319:332-337.
50. Gersh BJ, Califf RM, Loop FD, Akins CW, Pryor DB, Takaro TC. Coronary by-pass surgery in chronic stable angina. Circulation 1989;79 Suppl 1:I46-I59.
51. Ulvenstam G, Bergstrand R, Johansson S, Vedin A, Wilhelmsson C, Wedel H, Wilhelmsen L Prognostic importance of cholesterol levels after myocardial infarction. Prev Med. 13:1984;355-366.
52. Watts GF, Mandalia S, Slavin BM, Brunt JN, Coltart DJ, Lewis B Metabolic determinants of the course of coronary artery disease in men. Clin Chem. 40:1994;2240-2246.
53. Marburger C, Hambrecht R, Niebauer J, Schoeppenthau M, Scheffler E, Hauer K, Schuler G, Schlierf G Association between lipoprotein(a) and progression of coronary artery disease in middle-aged men. Am J Cardiol. 73:1994;742-746.
54. Terres W, Tatsis E, Pfalzer B, Beil FU, Beisiegel U, Hamm CW Rapid progression of coronary artery disease in patients with elevated lipoprotein(a). Circulation. 91:1995;948-950.
55. Desmarais RL, Sarembock IJ, Ayers CR, Vernon SM, Powers ER, Gimple LW Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty. Circulation. 91:1995;1403-1409.
56. Cooke T, Sheahan R, Filey D, Reilly M, D'Arcy G, Jauch W, Gibney M, Gearty G, Crean P, Walsh M Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease. Circulation. 89:1994;1593-1598.
57. Miyata M, Biro S, Arima S, Hamasaki S, Kaieda H, Nakao S, Kawataki M, Nomoto K, Tanaka H High serum concentration of lipoprotein(a) is a risk factor for restenosis after percutaneous transluminal coronary angioplasty in Japanese patients with single-vessel disease. Am Heart J. 132:1996;269-273.